EP2797915

2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    26.12.2012
  • :
    13.7.2016
  • :
    12812498.9
  • :
    25.12.2032
  • :
    2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure

26.12.2012
13.7.2016
  • :
    Ironwood Pharmaceuticals, Inc.
  • :
    301 Binney Street, 2nd Floor, 02142, Cambridge, MA, US
  • :
    KIM, Charles
  • :
    Cambridge, MA, US
  • :
    NAKAI, Takashi
  • :
    Newton, MA, US
  • :
    MOORE, Joel
  • :
    Lexington, MA, US
  • :
    PERL, Nicholas, Robert
  • :
    Apt. 44, Brookline, MA 02446, US
  • :
    IM, G-yoon, Jamie
  • :
    Cambridge, MA, US
  • :
    BARDEN, Timothy, Claude
  • :
    Salem, MA, US
  • :
    IYENGAR, Rajesh, R.
  • :
    West Newton, MA, US
  • :
    ZIMMER, Daniel, P.
  • :
    Somerville, MA, US
  • :
    FRETZEN, Angelika
  • :
    Somerville, MA, US
  • :
    RENHOWE, Paul, Allan
  • :
    Sudbury, MA, US
  • :
    201161580439 P
  • :
    27.12.2011
  • :
    US
  • :
    201261654580 P
  • :
    1.6.2012
  • :
    US
  • :
    WO2013101830
  • :
    26.12.2012
  • :
    C07D 413/14, C07D 403/04, C07D 417/14, A61K 31/4155, A61P 43/00